Figure 1

Analyse of the disease-free survival (A) and overall survival (B) as a function of pathological response after neoadjuvant chemotherapy. Pathological response was evaluated according to Chevallier's classification (Chevallier et al, 1993). Survival was analysed in patients with Class I response vs in patients with Classes II, III, IV responses.